Sinopsis

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Episodios

  • QNatal® Advanced: Understanding Prenatal Screening

    QNatal® Advanced: Understanding Prenatal Screening

    23/07/2020

    Guest: Carrie Guy QNatal® Advanced is a noninvasive, prenatal, cell-free DNA (cfDNA) screen that can be ordered as early as 10 weeks gestation. This test utilizes Next-Generation Sequencing (NGS) technology and superior bioinformatics to ensure high sensitivity, specificity, and PPV. Here to walk us through the QNatal Advanced screening test and how the results are reported is Carrie Guy, a Certified Genetic Counselor and the Product Manager for Women's Health at Quest Diagnostics.

  • NIPT: Tips for Counseling Your Patient

    NIPT: Tips for Counseling Your Patient

    22/07/2020

    Host: Kelly Chen, MS, LCGC Joining us is Senior Genetic Counselor Kelly Chen, who shares some counseling tips clinicians can use when talking to patients about non-invasive prenatal testing (NIPT), key factors to consider when reviewing an NIPT result, and the three potential results of the Harmony prenatal test, which screens for Down syndrome, trisomy 18, and trisomy 13. Kelly Chen, MS, LCGC, is no longer employed nor associated with Roche Diagnostics

  • Family Planning in Multiple Sclerosis: Enhancing Patient Care

    Family Planning in Multiple Sclerosis: Enhancing Patient Care

    16/07/2020

    Host: Matt Birnholz, MD Guest: Maria K. Houtchens, MD Guest: Maria Lopes, MD Patients with multiple sclerosis (MS) are increasingly choosing to start families. It is incumbent on us as healthcare professionals to try to ensure their chances for healthy pregnancies while maintaining adequate disease control. In this program, Dr. Houtchens and Dr. Lopes discuss the importance of patient/healthcare provider partnerships in family planning. Specific points of focus include the role of effective contraception, key concepts regarding the use of disease modifying therapies, and important practical considerations related to patient care in the time before, during, and after pregnancy. EMD Serono is a business of Merck KGaA, Darmstadt, Germany. ©EMD Serono, Inc. All rights reserved. US/NPR/1019/0558a

  • Innovative Nutritional Intervention: A Science-Based Approach to Supporting Metabolic Health

    Innovative Nutritional Intervention: A Science-Based Approach to Supporting Metabolic Health

    01/07/2020

    Host: Jennifer Caudle, DO Guest: Joanna Mitri, MD, MS Guest: Pouya Shafipour, MD There are numerous studies being conducted around the world examining various fasting modalities and their impact on the body and overall health. One increasingly popular approach is the Fasting Mimicking Diet® (FMD®). In this informative video you’ll gain a greater understanding of how this new and exciting nutritional intervention compares with other types of fasts, and how it works to elicit a host of positive effects that can help support healthy aging. Tune in as Drs. Joanna Mitri and Pouya Shafipour share their expertise on the topic of fasting, and the extraordinary benefits that can be achieved through the FMD. And for the ultimate nutritional intervention for supporting and maintaining metabolic health, there’s ProLon Professional— a thoroughly researched, 5-day, plant-based meal program designed to get your patients get back on track and be as effective as 120 days of Mediterranean Diet in just 4 cycles of the

  • CINtec PLUS Cytology: A New Biomarker-Based Triage in Cervical Cancer Screening

    CINtec PLUS Cytology: A New Biomarker-Based Triage in Cervical Cancer Screening

    30/06/2020

    Host: Jennifer Caudle, DO Guest: Ritu Nayar, MD The Pap test has played a key role in reducing cervical cancer since its introduction in the 1940s, but like any test, it isn’t without its limitations. Joining Dr. Jennifer Caudle to discuss how CINtec PLUS Cytology, a biomarker-based cytology test, aims to overcome those challenges is Dr. Ritu Nayar.

  • Postmenopausal Osteoporosis: Managing Patients at High Risk for Fracture

    Postmenopausal Osteoporosis: Managing Patients at High Risk for Fracture

    12/06/2020

    Guest: David W. Dempster, PhD, FRMS Just as a heart attack is an urgent indicator of heart disease, a fragility fracture in a postmenopausal woman signals that she may have underlying postmenopausal osteoporosis, and there should be urgency to treat the disease. Joining us to share some historical perspectives on postmenopausal osteoporosis and information about TYMLOS (abaloparatide), a treatment option for those patients with postmenopausal osteoporosis at high risk for fracture, is Dr. David Dempster.

  • Key Data on a First-Line Treatment Option for EGFRm mNSCLC

    Key Data on a First-Line Treatment Option for EGFRm mNSCLC

    10/06/2020

    Host: Jennifer Caudle, DO Guest: Tracey Evans, MD Join Dr. Tracey Evans as she discusses the efficacy data for TAGRISSO® (osimertinib) and the potential impact for metastatic EGFRm NSCLC patients. In 2018, first-line TAGRISSO became a standard of care for metastatic EGFRm NSCLC with an unprecedented 18.9 months median PFS vs 10.2 months for erlotinib/gefitinib (HR=0.46 [95% CI: 0.37, 0.57]; P<0.0001).1 Now, TAGRISSO is the only EGFR TKI to deliver statistically significant Overall Survival beyond 3 years in a global, phase 3 randomized clinical trial in the first-line setting, (38.6 months vs 31.8 months for erlotinib/gefitinib (HR=0.799 [95.05% CI: 0.641, 0.997]; P=0.0462)).2 Visit TagrissoHCP.com to learn what these data could mean for your patients. FLAURA study design: Randomized, double-blind, active-controlled trial in 556 patients with metastatic EGFRm NSCLC who had not received prior systemic treatment for advanced disease. Patients were randomized 1:1 to either TAGRISSO (n=279; 80 mg orally

  • Monoclonal Antibodies  Small Molecules: What Clinicians Need to Know

    Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know

    22/05/2020

    Host: Jennifer Caudle, DO Guest: Peter McAllister, MD While both small molecule drugs and monoclonal antibodies are considered targeted therapies, they each have unique characteristics that may influence how they’re used to treat diseases. That’s why Dr. Peter McAllister is here to explain how these two modalities differ in terms of structure, administration routes, and distribution. USA-334-83595

  • Unexplained Hematologic Abnormalities: Could It Be Type 1 Gaucher Disease?

    Unexplained Hematologic Abnormalities: Could It Be Type 1 Gaucher Disease?

    19/05/2020

    Host: Matt Birnholz, MD Guest: Joel Weinthal, MD Type 1 Gaucher disease is a progressive and lifelong genetic disease, and when the diagnosis is missed, this can lead to some serious implications or consequences. And since hematologists-oncologists play a pivotal role in identifying and diagnosing these patients, Dr. Matt Birnholz speaks with Dr. Joel Weinthal, Medical Director at Medical City Hospital, about the symptoms of Gaucher disease hematologists-oncologists should look for, how to test and diagnose, the consequences of diagnostic delays, and more. MAT-US-2003112 5/2020

  • Nutrition in the ICU: The Power of Protein in Critically Ill Patients

    Nutrition in the ICU: The Power of Protein in Critically Ill Patients

    12/05/2020

    Guest: Juan Ochoa, MD Join Dr. Juan Ochoa, Medical Director of Surgical Intensive Care at Oschsner Medical Center, as he reviews a retrospective study that investigated the impacts of high-protein, low-calorie feedings on critically ill patients in the ICU. Dr. Ochoa is a Surgeon, physician scientist, and former Chief Medical Officer of Nestlé Health Science.

  • What Bit Him: An Expert Perspective on Snake Antivenom

    What Bit Him: An Expert Perspective on Snake Antivenom

    27/04/2020

    Guest: Mark Ryan, PharmD The more time that passes before a snake bite is treated, the higher the risk of long-term or even permanent morbidity due to tissue damage. So when time is tissue, why risk it? Join Dr. Mark Ryan from the Louisiana Poison Control Center as he shares important information on the antivenom CroFab®, including its development, how it quickly controls envenomation effects, and its demonstrated safety profile.

  • Navigating the Snake Bite Treatment Algorithm

    Navigating the Snake Bite Treatment Algorithm

    27/04/2020

    Guest: Spencer Greene, MD, MS, FACEP, FACMT, FAAEM The Unified Treatment Algorithm is a consensus guideline prepared by a panel of experts that provides a simple, step-by-step guide on assessing and treating a patient who’s been bitten by a pit viper. Knowing the correct treatment approach is just as important as understanding what not to do, as Dr. Spencer Greene explains.

  • The 3 Critical Aspects of Snake Bite Management

    The 3 Critical Aspects of Snake Bite Management

    27/04/2020

    Guest: William Banner, MD, PhD Tissue damage caused by North American pit viper envenomation occurs quickly in snake bite victims. Join Dr. Bill Banner as he discusses three critical aspects of snake bite management and how treatment with CroFab® can be a viable option for patients.

  • Multiple Sclerosis  Aging: Considerations for Diagnosis  Treatment

    Multiple Sclerosis & Aging: Considerations for Diagnosis & Treatment

    23/04/2020

    Host: Jennifer Caudle, DO Guest: Riley Bove, MD Guest: Bianca Weinstock-Guttman, MD The disease course of multiple sclerosis (MS) can take many paths based on numerous factors, including age at diagnosis, gender, and MS subtype. Layered upon the typical MS management challenges are those that can occur with the physical and physiological changes of the normal aging process. How might the care of a patient with MS need to be modified as they age? In this discussion, Dr. Bove and Dr. Weinstock-Guttman will review: The effects that aging may have on patients with MS The interplay between menopause and MS How aging may affect the approach to disease management EMD Serono is a business of Merck KGaA, Darmstadt, Germany. ©EMD Serono, Inc. All rights reserved. US/NPR/1019/0520B

  • Insights on an IBS-D Therapy that Can Help Relieve Symptoms

    Insights on an IBS-D Therapy that Can Help Relieve Symptoms

    20/04/2020

    Guest: Gregory S. Sayuk, MD, MPH Please click here for full Prescribing Information. Irritable bowel syndrome with diarrhea can have a significant impact on patients’ daily activities due to debilitating symptoms like abdominal pain and diarrhea, both of which could be a result of alterations in the gut microbiota. Joining us to discuss XIFAXAN (rifaximin), the only FDA-approved treatment that alters the gut microbiota in IBS-D, is Dr. Gregory Sayuk.

  • Exploring the Underdiagnosis of AS Within  Around Rheumatology Practices

    Exploring the Underdiagnosis of AS Within & Around Rheumatology Practices

    08/04/2020

    Host: Matt Birnholz, MD Guest: Sanjay Chabra, MD As stated by Dr. Sanjay Chabra, "About 19 percent of the population lives with chronic back pain, but what about when it’s inflammatory—not mechanical—back pain?" Join Dr. Matt Birnholz as he sits down with Dr. Chabra at the 2019 American College of Rheumatology annual meeting in Atlanta, Georgia, to share strategies that can help us shorten the delay in the diagnosis of ankylosing spondylitis that often occurs within and around rheumatology practices. PP-IX-US-3710 04/2020 ©Lilly USA, LLC 2020. All rights reserved.

  • Uncovering Hidden Clues in Diagnosing Psoriatic Arthritis

    Uncovering Hidden Clues in Diagnosing Psoriatic Arthritis

    08/04/2020

    Host: Matt Birnholz, MD Guest: Roger Kornu, MD To help address the gap in awareness across the field regarding the development of psoriatic arthritis, Dr. Roger Kornu joins Dr. Matt Birnholz at the 2019 American College of Rheumatology annual meeting in Atlanta, Georgia, to discuss commonly overlooked symptoms, including plaque psoriasis, dactylitis, and enthesitis. PP-IX-US-3710 04/2020 ©Lilly USA, LLC 2020. All rights reserved.

  • Dietary Understandings  Updates for Rheumatoid Arthritis Patients

    Dietary Understandings & Updates for Rheumatoid Arthritis Patients

    17/03/2020

    Host: Matt Birnholz, MD Guest: Smitha Reddy, MD Join Dr. Matt Birnholz as he sits down with Dr. Smitha Reddy at the annual rheumatology meeting in Atlanta, Georgia to explore how an anti-inflammatory diet could have an impact on a rheumatoid arthritis patient's lifestyle. PP-BA-US-1149 2/2020 ©Lilly USA, LLC 2020. All rights reserved.

  • Early Signs  Symptoms of Rheumatoid Arthritis

    Early Signs & Symptoms of Rheumatoid Arthritis

    17/03/2020

    Host: Matt Birnholz, MD Guest: Ara Dikranian, MD Did you know joint stiffness and tenderness as well as joint pain could be early signs and symptoms of rheumatoid arthritis? Once symptoms are identified, how do you know which patients should be referred to a rheumatologist? Answering those and other questions is Dr. Ara Dikranian, who sat down with Dr. Matt Birnholz at the annual rheumatology meeting in Atlanta, Georgia. PP-BA-US-1143 2/2020 ©Lilly USA, LLC 2020. All rights reserved.

  • Making a Difference for Patients with sHPT

    Making a Difference for Patients with sHPT

    16/03/2020

    Host: John J. Russell, MD Guest: David Henner, DO Guest: Abdul Abdellatif, MD, FASN With the ever-increasing pace and pressures faced by nephrology professionals both in the office and at the dialysis center, how can you keep up? John Russell, MD welcomes two community nephrologists, David Henner, DO from Pittsfield, Massachusetts, and Adbul Abdellatif, MD, FASN from Houston, Texas, to talk about just that. Together, they explore how nephrologists are dealing with the changing landscape of nephrology and how a drug called Parsabiv® is playing a role in the important work they do. This promotional, non-CME program is intended for US Health Care Professionals. David Henner, DO and Adbul Abdellatif, MD, FASN were paid a fee by Amgen for their participation in the program.

página 1 de 3

Informações: